DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis
USA - NASDAQ:DHCNI - US25525P2065
17.05 USD
0 (0%)
Overall DHCNI gets a fundamental rating of 2 out of 10. We evaluated DHCNI against 127 industry peers in the Diversified REITs industry. DHCNI may be in some trouble as it scores bad on both profitability and health. DHCNI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DHCNI had negative earnings in the past year.
In the past year DHCNI had a positive cash flow from operations.
In the past 5 years DHCNI reported 4 times negative net income.
In multiple years DHCNI reported negative operating cash flow during the last 5 years.
1.2 Ratios
DHCNI has a worse Return On Assets (-6.03%) than 85.04% of its industry peers.
The Return On Equity of DHCNI (-15.46%) is worse than 80.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.03% | ||
| ROE | -15.46% | ||
| ROIC | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of DHCNI (17.80%) is worse than 93.70% of its industry peers.
In the last couple of years the Gross Margin of DHCNI has declined.
The Profit Margin and Operating Margin are not available for DHCNI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.8% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
2. Health
2.1 Basic Checks
DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
DHCNI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DHCNI has more shares outstanding
DHCNI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.35, we must say that DHCNI is in the distress zone and has some risk of bankruptcy.
DHCNI has a worse Altman-Z score (0.35) than 60.63% of its industry peers.
A Debt/Equity ratio of 1.42 is on the high side and indicates that DHCNI has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.42, DHCNI is in line with its industry, outperforming 44.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.42 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.35 |
ROIC/WACCN/A
WACC6.65%
2.3 Liquidity
DHCNI has a Current Ratio of 3.37. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.37, DHCNI belongs to the top of the industry, outperforming 93.70% of the companies in the same industry.
DHCNI has a Quick Ratio of 3.37. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
DHCNI has a Quick ratio of 3.37. This is amongst the best in the industry. DHCNI outperforms 93.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.37 | ||
| Quick Ratio | 3.37 |
3. Growth
3.1 Past
DHCNI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.96%, which is quite impressive.
The Revenue has been growing slightly by 6.04% in the past year.
DHCNI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.
EPS 1Y (TTM)41.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
3.2 Future
DHCNI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.25% yearly.
The Revenue is expected to grow by 3.37% on average over the next years.
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
DHCNI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DHCNI is valued expensively inside the industry as 93.70% of the companies are valued cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 27.75 |
4.3 Compensation for Growth
DHCNI's earnings are expected to grow with 17.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.25%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.90%, DHCNI is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.40, DHCNI's dividend is way lower than its industry peers. On top of this 91.34% of the companies listed in the same industry pay a better dividend than DHCNI!
Compared to an average S&P500 Dividend Yield of 2.38, DHCNI's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
5.2 History
The dividend of DHCNI decreases each year by -45.60%.
DHCNI has been paying a dividend for over 5 years, so it has already some track record.
DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
DHCNI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.36%
EPS Next 2Y17.25%
EPS Next 3YN/A
DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42
NASDAQ:DHCNI (11/4/2025, 3:06:43 PM)
17.05
0 (0%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners75.89%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.12B
Revenue(TTM)1.50B
Net Income(TTM)-286760000
Analysts48
Price Target17.51 (2.7%)
Short Float %0%
Short Ratio0.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.9% |
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-3.36%
Div Incr Years0
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.74%
Min EPS beat(2)-71.02%
Max EPS beat(2)122.5%
EPS beat(4)2
Avg EPS beat(4)34.05%
Min EPS beat(4)-71.02%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)16.12%
EPS beat(12)4
Avg EPS beat(12)5.38%
EPS beat(16)4
Avg EPS beat(16)-11.59%
Revenue beat(2)0
Avg Revenue beat(2)-0.26%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)-0.04%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-0.38%
Revenue beat(16)4
Avg Revenue beat(16)-1.01%
PT rev (1m)14.99%
PT rev (3m)8.74%
EPS NQ rev (1m)-2.38%
EPS NQ rev (3m)-7.5%
EPS NY rev (1m)0.6%
EPS NY rev (3m)-27.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 2.7 | ||
| P/FCF | N/A | ||
| P/OCF | 46.19 | ||
| P/B | 2.22 | ||
| P/tB | 2.22 | ||
| EV/EBITDA | 27.75 |
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)0.37
OCFY2.16%
SpS6.31
BVpS7.68
TBVpS7.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.03% | ||
| ROE | -15.46% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.8% | ||
| FCFM | N/A |
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.42 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 11.07 | ||
| Cap/Depr | 66.82% | ||
| Cap/Sales | 12.33% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 37.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.37 | ||
| Quick Ratio | 3.37 | ||
| Altman-Z | 0.35 |
F-Score6
WACC6.65%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y20.64%
EPS Next 2Y17.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.04%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.03%
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year377.31%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y71.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y283.65%
OCF growth 3YN/A
OCF growth 5Y-15.84%
DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 / DHCNI FAQ
Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?
ChartMill assigns a fundamental rating of 2 / 10 to DHCNI.
Can you provide the valuation status for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?
ChartMill assigns a valuation rating of 0 / 10 to DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI). This can be considered as Overvalued.
How profitable is DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?
DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) has a profitability rating of 1 / 10.
Can you provide the financial health for DHCNI stock?
The financial health rating of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is 3 / 10.